Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
argenx Announces Annual General Meeting of Shareholders on May 7, 2024 | ||
By: GlobeNewswire - 26 Mar 2024 | Back to overview list |
|
March 26, 2024 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that the Annual General Meeting of shareholders will be held at 13:00 CET on Tuesday, May 7, 2024 at the Hilton Amsterdam Schiphol at Schiphol Boulevard 701, 1118 BN Schiphol, the Netherlands. The company’s annual report for the financial year ended December 31, 2023 is now available on its website www.argenx.com/investors/financial-reports. Agenda The full agenda for the meeting as well as all ancillary documents relevant for the meeting are available via the argenx website and are also available for inspection at the argenx offices. A free copy thereof may also be obtained by e-mailing legal@argenx.com. argenx would like to encourage shareholders to use the voting by (electronic) proxy option as referred to in the convocation. About argenx For further information, please contact: Media: Ben Petok Investors: Alexandra Roy (US) Lynn Elton (EU) |
||
|
||
Copyright 2024 GlobeNewswire | Back to overview list |